{
    "root": "c8cab0b8-d63c-4e62-b95e-c174b0b663c9",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Hydroxyzine Hydrochloride",
    "value": "20250523",
    "ingredients": [
        {
            "name": "HYDROXYZINE DIHYDROCHLORIDE",
            "code": "76755771U3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_5818"
        },
        {
            "name": "FD&C BLUE NO. 2--ALUMINUM LAKE",
            "code": "4AQJ3LG584"
        },
        {
            "name": "HYPROMELLOSE 2910 (3 MPA.S)",
            "code": "0VUT3PMY82",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE 101",
            "code": "7T9FYH5QMK",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "POLYSORBATE 80",
            "code": "6OZP39ZG8H",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_53426"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "D&C RED NO. 7",
            "code": "ECW0LZ41X8"
        }
    ],
    "indications": {
        "text": "symptomatic relief anxiety tension associated psychoneurosis adjunct organic disease states anxiety manifested . useful management pruritus due allergic conditions chronic urticaria atopic contact dermatoses histamine-mediated pruritus . sedative used premedication following general anesthesia , hydroxyzine may potentiate meperidine barbiturates , pre-anesthetic adjunctive therapy modified individual basis . atropine belladonna alkaloids affected . hydroxyzine known interfere action digitalis way may used concurrently agent . effectiveness hydroxyzine antianxiety agent long term , 4 months , assessed systematic . physician reassess periodically usefulness individual patient .",
        "doid_entities": [
            {
                "text": "anxiety (DOID:2030)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_2030"
            },
            {
                "text": "psychoneurosis (DOID:4964)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4964"
            },
            {
                "text": "disease (DOID:4)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4"
            },
            {
                "text": "chronic urticaria (DOID:0080747)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0080747"
            },
            {
                "text": "urticaria (DOID:1555)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1555"
            }
        ],
        "orphanet_entities": [
            {
                "disease": "chronic urticaria atopic",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_182734"
            }
        ]
    },
    "contraindications": {
        "text": "symptomatic relief anxiety tension associated psychoneurosis adjunct organic disease states anxiety manifested : adults , 50 100 mg q.i.d . ; children 6 years , 50 mg daily divided doses ; children 6 years , 50 100 mg daily divided doses . management pruritus due allergic conditions chronic urticaria atopic contact dermatoses histamine-mediated pruritus : adults , 25 mg t.i.d . q.i.d . ; children 6 years , 50 mg daily divided doses ; children 6 years , 50 100 mg daily divided doses . sedative used premedication following general anesthesia : 50 100 mg adults 0.6 mg/kg body weight children . treatment initiated intramuscular route , subsequent doses may administered orally . potent medication , adjusted according patient 's response therapy .",
        "doid_entities": [
            {
                "text": "anxiety (DOID:2030)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_2030"
            },
            {
                "text": "psychoneurosis (DOID:4964)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4964"
            },
            {
                "text": "disease (DOID:4)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4"
            },
            {
                "text": "chronic urticaria (DOID:0080747)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0080747"
            },
            {
                "text": "urticaria (DOID:1555)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1555"
            }
        ],
        "orphanet_entities": [
            {
                "disease": "chronic urticaria atopic",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_182734"
            }
        ]
    },
    "warningsAndPrecautions": "hydroxyzine hydrochloride tablets usp , 50 mg purple , round , biconvex , film-coated tablets debossed `` 7 `` one side plain side . ndc : 72162-2513-1 : 100 tablets bottle ndc : 72162-2513-5 : 500 tablets bottle ndc : 72162-2513-0 : 1000 tablets bottle storage store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) [ usp controlled room temperature ] . dispense tight container defined usp , child-resistant closure ( required ) . keep medications reach children . repackaged/relabeled : bryant ranch prepack , inc.burbank , ca 91504",
    "adverseReactions": "oral hydroxyzine hydrochloride contraindicated patients known hypersensitivity hydroxyzine hydrochloride products , patients known hypersensitivity cetirizine hydrochloride levocetirizine hydrochloride . hydroxyzine contraindicated patients prolonged qt interval . hydroxyzine , administered pregnant mouse , rat , rabbit induced fetal abnormalities rat mouse doses substantially human therapeutic range . data human beings inadequate establish safety early pregnancy . data available , hydroxyzine contraindicated early pregnancy . hydroxyzine contraindicated patients shown previous hypersensitivity component medication .",
    "indications_original": "For symptomatic relief of anxiety and tension associated with psychoneurosis and as an adjunct in organic disease states in which anxiety is manifested.\n                  \n                  Useful in the management of pruritus due to allergic conditions such as chronic urticaria and atopic and contact dermatoses and in histamine-mediated pruritus.\n                  \n                  As a sedative when used as a premedication and following general anesthesia, hydroxyzine may potentiate meperidine and barbiturates, so their use in pre-anesthetic adjunctive therapy should be modified on an individual basis. Atropine and other belladonna alkaloids are not affected by the drug. Hydroxyzine is not known to interfere with the action of digitalis in any way and it may be used concurrently with this agent.\n                  \n                  The effectiveness of hydroxyzine as an antianxiety agent for long term use, that is more than 4 months, has not been assessed by systematic clinical studies. The physician should reassess periodically the usefulness of the drug for the individual patient.",
    "contraindications_original": "For symptomatic relief of anxiety and tension associated with psychoneurosis and as an adjunct in organic disease states in which anxiety is manifested: adults, 50 to 100 mg q.i.d.; children under 6 years, 50 mg daily in divided doses; children over 6 years, 50 to 100 mg daily in divided doses.\n                  \n                  For use in the management of pruritus due to allergic conditions such as chronic urticaria and atopic and contact dermatoses and in histamine-mediated pruritus: adults, 25 mg t.i.d. or q.i.d.; children under 6 years, 50 mg daily in divided doses; children over 6 years, 50 to 100 mg daily in divided doses.\n                  \n                  As a sedative when used as a premedication and following general anesthesia: 50 to 100 mg for adults and 0.6 mg/kg of body weight in children.\n                  \n                  When treatment is initiated by the intramuscular route of administration, subsequent doses may be administered orally.\n                  \n                  As with all potent medication, the dosage should be adjusted according to the patient's response to therapy.",
    "warningsAndPrecautions_original": "Hydroxyzine Hydrochloride Tablets USP, 50 mg are purple, round, biconvex, film-coated tablets debossed with \"7\" on one side and plain on other side.\n                  NDC: 72162-2513-1: 100 Tablets in a BOTTLE\n                  NDC: 72162-2513-5: 500 Tablets in a BOTTLE\n                  NDC: 72162-2513-0: 1000 Tablets in a BOTTLE\n                  STORAGE\n                  Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F) [see USP Controlled Room Temperature].Dispense in a tight container as defined in the USP, with a child-resistant closure (as required).\n                  KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.\n                  Repackaged/Relabeled by:Bryant Ranch Prepack, Inc.Burbank, CA 91504",
    "adverseReactions_original": "Oral hydroxyzine hydrochloride is contraindicated in patients with known hypersensitivity to hydroxyzine hydrochloride products, and in patients with known hypersensitivity to cetirizine hydrochloride or levocetirizine hydrochloride.\n                  \n                  Hydroxyzine is contraindicated in patients with a prolonged QT interval.\n                  \n                  Hydroxyzine, when administered to the pregnant mouse, rat, and rabbit induced fetal abnormalities in the rat and mouse at doses substantially above the human therapeutic range. Clinical data in human beings are inadequate to establish safety in early pregnancy. Until such data are available, hydroxyzine is contraindicated in early pregnancy.\n                  \n                  Hydroxyzine is contraindicated for patients who have shown a previous hypersensitivity to \n                  \n                  \n                  any component of this medication.",
    "drug": [
        {
            "name": "Hydroxyzine Hydrochloride",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_5819"
        }
    ]
}